Hyderabad Telangana, India

Reddy Kesireddy Subash Chander


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Hyderabad, IN (2007 - 2009)
  • Andhrapradesh, IN (2009)

Company Filing History:


Years Active: 2007-2009

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Reddy Kesireddy Subash Chander: Innovator in Pharmaceutical Crystallization

Introduction

Reddy Kesireddy Subash Chander is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel crystalline forms of various compounds. With a total of seven patents to his name, his work has had a substantial impact on drug formulation and delivery.

Latest Patents

Among his latest patents are innovative crystalline forms of donepezil hydrochloride. This invention provides novel crystalline forms, processes for their preparation, and pharmaceutical compositions containing them. Additionally, he has developed crystalline forms of lamotrigine, which also includes processes for their preparation and related pharmaceutical compositions. These advancements are crucial for enhancing the efficacy and stability of these medications.

Career Highlights

Reddy Kesireddy Subash Chander is currently associated with Hetero Drugs Limited, a leading pharmaceutical company. His role involves extensive research and development, focusing on improving drug formulations through innovative crystallization techniques. His expertise has positioned him as a key player in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Reddy Bandi Parthasaradhi and Reddy Kura Rathnakar. Their collaborative efforts have contributed to the successful development of various pharmaceutical innovations.

Conclusion

Reddy Kesireddy Subash Chander's contributions to pharmaceutical crystallization exemplify the importance of innovation in drug development. His patents not only enhance the effectiveness of existing medications but also pave the way for future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…